Dolby Laboratories (DLB)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 188,262 | 200,656 | 219,226 | 242,424 | 183,448 | 184,087 | 200,522 | 215,546 | 255,043 | 310,227 | 292,865 | 305,529 | 317,808 | 231,363 | 248,452 | 220,741 | 205,685 | 255,151 | 237,949 | 201,491 |
| Total stockholders’ equity | US$ in thousands | 2,345,850 | 2,355,100 | 2,366,240 | 2,350,780 | 2,287,580 | 2,246,180 | 2,454,360 | 2,599,770 | 2,637,750 | 2,597,980 | 2,621,520 | 2,587,930 | 2,565,160 | 2,432,640 | 2,431,370 | 2,364,060 | 2,333,290 | 2,307,350 | 2,314,520 | 2,347,020 |
| ROE | 8.03% | 8.52% | 9.26% | 10.31% | 8.02% | 8.20% | 8.17% | 8.29% | 9.67% | 11.94% | 11.17% | 11.81% | 12.39% | 9.51% | 10.22% | 9.34% | 8.82% | 11.06% | 10.28% | 8.58% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $188,262K ÷ $2,345,850K
= 8.03%
The return on equity (ROE) for Dolby Laboratories has shown fluctuation over the quarters provided in the data table. ROE measures a company's profitability by evaluating how effectively it is generating profits from its shareholders' equity.
From December 2019 to December 2023, Dolby Laboratories' ROE has ranged from 8.02% to 12.39%. Overall, the trend indicates a moderate level of return on equity with some variability in performance quarter to quarter.
The company experienced a peak ROE of 12.39% in March 2021, which suggests strong profitability relative to shareholder equity at that time. However, in recent quarters, the ROE has decreased to levels below 10% but remained relatively stable within this range.
It is essential for investors and stakeholders to monitor Dolby Laboratories' ROE consistently to assess the company's ability to efficiently generate profits using shareholders' equity. Fluctuations and trends in ROE can provide valuable insights into the company's financial performance and management's effectiveness in utilizing shareholder funds to generate returns.
Peer comparison
Dec 31, 2023